The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study (IMMCO-1) of atezolizumab plus tivozanib in castrate-resistant prostate cancer and certain other immunologically cold tumors.
 
Jonathan Alexander Chatzkel
Travel, Accommodations, Expenses - Lilly; Merck
 
Ji-Hyun Lee
No Relationships to Disclose
 
Azka Ali
No Relationships to Disclose
 
Carmen Joseph Allegra
No Relationships to Disclose
 
Paul Crispen
No Relationships to Disclose
 
Dennie V. Jones
No Relationships to Disclose
 
Padraic O'Malley
Consulting or Advisory Role - Inherent imaging Inc
 
Thomas J. George
Consulting or Advisory Role - Tempus
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Seagen (Inst); Tesaro (Inst)
 
Brian Hemendra Ramnaraign
No Relationships to Disclose